Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kova vs Somi Health

Kova
Graded #498

Lower grade

vs+24.400000000000006
Somi Health
Graded #141

Higher grade

The verdict

Somi Health takes it — 68.7/100 to 44.3/100.

Somi Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Somi Health is a telehealth weight-loss provider offering compounded GLP-1 medications - compounded semaglutide and tirzepatide injections plus an oral semaglutide tablet.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSomi Health +46
20
66
Dose & formulationSomi Health +35
40
75
Clinical oversightSomi Health +11
71
82
Labs & monitoringSomi Health +1
52
53
FulfillmentSomi Health +15
61
76
Contract termsSomi Health +22
25
47
Kova · left barSomi Health · right bar

The numbers

MetricKovaSomi Health
WeighScore44.3/10068.7/100
GradeCC
Scorecard rank#498#141
SemaglutideNot disclosed$135/mo (starting dose, compounded)
TirzepatideNot disclosed$165/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Kova

Graded #498 · C

Strengths

  • Publishes the full price ladder for all three plan terms — intro month and renewal rate — directly in its FAQ
  • Medication is included in the plan price, with no separate pharmacy charge
  • States plainly that its compounded GLP-1s are 'not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality'
  • Companion app tracks weight, protein and side effects, with medication schedule reminders
  • You are not charged unless a provider approves treatment

Where it loses points

  • At $449 per 4 weeks, the standing 1-month plan is among the most expensive compounded GLP-1 options we track
  • The advertised $129 is the 6-month plan's intro month only — that plan then renews at $1,794 every 24 weeks
  • Billed every 4 weeks rather than monthly, which is 13 charges a year instead of 12
  • Never names which GLP-1 molecule is dispensed — only 'compounded, non-FDA-approved GLP-1 medications'
  • No pharmacy or prescribing medical group is named anywhere on the site
Somi Health

Graded #141 · C

Strengths

  • Among the lowest compounded prices: semaglutide $135/mo, tirzepatide $165/mo (3-month plan)
  • Oral semaglutide tablet option for those who want no injections
  • One price at any dose, with the medical visit and shipping included
  • LegitScript Approved seal displayed; partnered with 503A pharmacies
  • Free 2-5 day shipping; no insurance required

Where it loses points

  • Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
  • Homepage advertises a 100% money-back guarantee but Terms state all sales are final, no refunds on medication
  • Partner pharmacies are not individually named (material transparency gap)
  • No single prescribing medical group named; only affiliated professional entities
  • State availability not published; confirmed only during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard